The causative agent of malaria, Plasmodium, replicates inside a membrane-bound parasitophorous vacuole (PV), which shields this intracellular parasite from the cytosol of the host cell 1 . One common threat for intracellular pathogens is the homeostatic process of autophagy, through which cells capture unwanted intracellular material for lysosomal degradation 2 . During the liver stage of a malaria infection, Plasmodium parasites are targeted by the autophagy machinery of the host cell, and the PV membrane (PVM) becomes decorated with several autophagy markers, including LC3 (microtubule-associated protein 1 light chain 3) 3,4 . Here we show that Plasmodium berghei parasites infecting hepatic cells rely on the PVM transmembrane protein UIS3 to avoid elimination by host-cell-mediated autophagy. We found that UIS3 binds host LC3 through a non-canonical interaction with a specialized surface on LC3 where host proteins with essential functions during autophagy also bind. UIS3 acts as a bona fide autophagy inhibitor by competing with host LC3-interacting proteins for LC3 binding. Our work identifies UIS3, one of the most promising candidates for a genetically attenuated vaccine against malaria 5 , as a unique and potent mediator of autophagy evasion in Plasmodium. We propose that the protein-protein interaction between UIS3 and host LC3 represents a target for antimalarial drug development.
). Consistent with previous reports 5 , uis3(−) parasites were virtually undetectable in control HepG2 cells, and the few hepatic schizonts observed 65 h after infection did not express MSP1, the merozoite surface marker seen in fully mature uis3(+) parasites (Fig. 1b,c and Supplementary Fig. 1c ). Strikingly, depletion of Atg5 or Rab7 in HepG2 cells was sufficient to fully revert the phenotype of uis3(−) mutants to a wild-type one (Fig. 1b,c and Supplementary  Fig. 1c ). With the autophagy flux of the host cell arrested, uis3(−) parasites behaved in the same way as their uis3(+) counterparts with respect to schizont abundance as well as MSP1 expression (Fig. 1b,c and Supplementary Fig. 1c ). Parasites that complete the liver stage successfully induce the release of blood-infective merozoite-filled sacs (merosomes) from infected cells 12 . To test the viability of the uis3(−) progeny released by HepG2-infected cells, we collected the cell culture supernatants (HepG2 SN) 65 h after infection, inoculated them into mice and monitored the onset of blood-stage infection by collecting blood samples daily (Fig. 1a ). HepG2 SN from Atg5-or Rab7-depleted cells infected with uis3(−) mutants caused patent blood-stage infections within 4-5 days of mice inoculation, similar to mice inoculated with HepG2 SN derived from uis3(+)-infected cells ( Fig. 1d-f ). In stark contrast, HepG2 SN collected from control uis3(−) infected cells did not cause infection in mice ( Fig. 1d-f ). Thus, loss of autophagy during the liver stage fully restores uis3(−) infectivity. Additionally, the survival rates of uis3(−) and uis3(+) parasites in Atg3, Atg5 or Atg7 knockout mouse embryonic fibroblasts (MEFs) were also identical, whereas few uis3(−) mutants survived in wild-type MEFs (Fig. 1g ). To obtain additional evidence that uis3(−) parasites are removed by host autophagy, newly invaded hepatoma cells were treated with chloroquine (CQ), a lysosomotropic alkalizing agent that impairs the lysosomal degradation of autophagic cargo. CQ treatment, like genetic impairment of autophagy, rescued uis3(−) mutants (Fig. 1h ). On rare occasions we were able to observe uis3(−) parasites that exhibited distinctive signs of having undergone fusion with LAMP1-positive lysosomes, most prominently, the presence of LAMP1 within the vacuole and loss of the PVM marker, UIS4 ( Supplementary Fig. 1d ). Thus, we conclude that uis3(−) mutants normally fail to establish liver-stage infections because they are promptly eliminated by host autophagy and that the critical function of UIS3 is to protect Plasmodium from this innate defence mechanism.
Next, we aimed to elucidate how UIS3 interferes with host autophagy. To that end, we complemented uis3(−) parasites with the UIS3 gene fused C-terminally to c-Myc (this parasite line will be referred Mean + s.e.m. of pooled replicates from two (Atg5, Rab7) to four (control) independent experiments normalized to the control. d, Representative images of Giemsa-stained blood smears from C57BL/6 mice 10 days after receiving the indicated HepG2 SN. e, Onset of blood-stage parasitaemia following inoculation of C57BL/6 mice with the indicated HepG2 SN. Animals that received control uis3(−) HepG2 SN remained parasite free up to 30 days after inoculation. Data represent the per cent of mice (out of 5 to 10; two independent experiments) with positive blood smears. f, Genotype of blood-stage parasites collected 10 days after mice inoculation with the indicated HepG2 SN. Wild-type and knockout uis3 genomic loci were amplified with specific primer sets. One representative mouse from each experimental group is shown. g, Control (Atg3 +/+ , Atg5 +/+ , Atg7 +/+ ) and autophagy-deficient MEFs (Atg3 −/− , Atg5 −/− and Atg7 −/− ) were infected with uis3(+) or uis3(−) parasites, fixed at 48 h and labelled with anti-PbHsp70 and Hoechst. EEF numbers were quantified by microscopy and normalized to the uis3(+) control of each cell line. Bars represent mean + s.e.m. of five independent experiments. h, Huh7 cells treated with chloroquine (CQ) from 1 h to 24 h after infection with uis3(+) or uis3(−) parasites were immunostained with anti-PbUIS4, anti-PbHsp70 and Hoechst. The numbers of EEFs were quantified by microscopy in three independent experiments. Statistical significance was assessed using non-parametric two-tailed Mann-Whitney test. NS, P > 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
Letters

NaTUre MICrObIOLOgy
to as uis3-myc) ( Supplementary Fig. 2 ). Immunofluorescence analysis of liver-stage schizonts revealed that UIS3-myc co-localized with host LC3 and UIS4 to the PVM (Fig. 2a,b and Supplementary  Fig. 3a,b ). Of note, immuno-electron microscopy showed LC3 in direct association with the PVM, with no evidence of autophagosomal double membranes-a hallmark of canonical autophagy-forming around the PV (Fig. 2c ). Prompted by these observations, we asked whether UIS3 might form a molecular complex with LC3. We allowed uis3-myc parasites to infect HeLa cells stably expressing GFP-LC3 and, 24 h after infection, proceeded to immunoprecipitate UIS3-myc. Strikingly, GFP-LC3 was found to co-immunoprecipitate with UIS3 ( Fig. 2d ). We further confirmed this association in P. berghei-infected mouse primary hepatocytes ( Supplementary  Fig. 3c ), thus ruling out the possibility of a potential artefact linked to GFP-LC3 over-expression. LC3 immunoprecipitation could not be detected in cells infected with uis3(−) mutants, which do not express UIS3 ( Fig. 2d and Supplementary Fig. 3c ). Next, we used recombinant UIS3 and LC3 to test whether the two proteins directly Letters NaTUre MICrObIOLOgy associate. Full-length UIS3 comprises a signal peptide, a short intravacuolar N-terminal domain, a transmembrane anchor and a C-terminal domain that spans residues 83-229 and is predicted to be exposed to the host cytosol. Previous studies reported that the C-terminal domain of P. falciparum UIS3 is prone to dimerization, but undergoes proteolytic cleavage in solution, yielding a stable and soluble monomeric fragment consisting of residues 130-229 (hereafter referred to as soluble UIS3, sPfUIS3) 13 . Using recombinant GST-LC3, we were able to pull down recombinant His-tagged sPfUIS3 ( Fig. 2e ). The dissociation constant (K D ) for the complex measured by surface plasmon resonance was 0.244 μ M ( Fig. 2f,g) . Despite being co-localized with both UIS3 and UIS4 on the PVM, LC3 was shown to co-immunoprecipitate with sPbUIS3, but not with the corresponding C-terminal domain of PbUIS4 ( Supplementary  Fig. 3d ). We also did not observe co-immunoprecipitation of L-FABP with recombinant sPfUIS3 ( Supplementary Fig. 3e ), in line with previous work suggesting that the reported interaction between the C terminus of Plasmodium yoelii UIS3 and mouse L-FAPB (ref. 14) might be species-specific 15 . Collectively, these data demonstrate that the distal C-terminal subdomain of UIS3, spanning amino acids 130-229, binds to LC3 directly. Our data establish that UIS3 forms a molecular complex with LC3, but the association of LC3 with the PVM was found to be host-driven (two core components of the LC3 conjugation system, Atg3 and Atg5, were shown to be essential) and independent of UIS3 ( Supplementary Fig. 4a-d ). In contrast, neither ULK1, the AMPK-regulated autophagy-initiating kinase, nor the autophagy receptors p62 and NDP52, all previously implicated in xenophagy 16 , were required ( Supplementary Fig. 4e -g). This is consistent with recent reports highlighting the role of Atg5 and the lack of involvement of the autophagy-initiation complex in targeting LC3 to the PVM (refs. 3, 17) . LC3 association with the PVM was also unaffected by reactive oxygen species (ROS) scavengers ( Supplementary  Fig. 4h ,i), implying that the host response against Plasmodium is mechanistically unrelated to LC3-associated phagocytosis (LAP). LAP has been described as a microbicidal pathway wherein elements of the LC3 conjugation system transfer LC3 in a ROS-dependent manner to pathogen-containing phagosomes 18 . Intriguingly, the pathway leading to Plasmodium targeting by autophagy appears to Supplementary Fig. 5d ,e). All key interacting amino acids are highlighted in black (LC3) and red (UIS3). P. falciparum (a,b) and P. berghei complexes (c,d) are shown. e,f, Lysates of GFP-LC3 HeLa cells expressing the indicated sPfUIS3 (e) or sPbUIS3 (f) myc-tagged proteins (amino acid substitutions shown on the left) were immunoprecipitated with anti-myc. Precipitates were analysed by western blot with anti-LC3 (top panels) and anti-myc (middle panels). TCL were immunoblotted with anti-LC3 (bottom panels). g, Relative contribution of single amino acid substitutions (shown on the left) to the binding of luciferase-tagged sPfUIS3 to recombinant GST-LC3. Inset: outline of the pulldown assay. The average + s.e.m. of two independent experiments is shown. h, CD spectra of sPfUIS3 recombinant proteins (wild-type and indicated mutants). Each spectrum is the average of 10 technical replicates, corrected for the buffer background. i, Immunoprecipitation of myc-tagged sPfUIS3 WT from HeLa cell lysates co-expressing the indicated HA-tagged LC3 proteins (amino acid substitutions shown on top). Precipitates were probed with anti-HA (top panel) and anti-myc (middle panel). The bottom panel shows the levels of LC3 in TLC. One representative immunoblot of at least three independent experiments is shown in e, f and i. Statistical significance was assessed using an unpaired two-tailed t-test. *P < 0.05; **P < 0.01; ****P < 0.0001. Letters NaTUre MICrObIOLOgy be inhibited by ULK1. Indeed, we observed significantly higher levels of PVM-associated LC3 upon knockdown of ULK1 expression ( Supplementary Fig. 4f ). These results confirm the unconventional nature of the host autophagy response against Plasmodium and imply that the association of LC3 to the PVM precedes the UIS3-LC3 interaction. Whereas LC3 binding partners typically contain an LC3interacting region (LIR) with the consensus sequence W/F-x-x-I/L/V (refs 19, 20 ) , UIS3 lacks this canonical LIR ( Supplementary  Fig. 5a ). To gain further insight on the specific mode of binding of UIS3 to LC3, we modelled the three-dimensional structure of the putative complex between sPfUIS3 or sPbUIS3 and LC3 using a molecular docking algorithm and the published X-ray structures of sPfUIS3 (ref. 13 ) and LC3B (ref. 21 ) (Fig. 3a-d and Supplementary  Fig. 5 ). Our in silico analysis predicted that the interaction is likely to be driven by a flexible turn between helices α 2 and α 3 of UIS3 (N181, M182 and E183 in P. falciparum UIS3) and the β 2 strand of LC3 ( Fig. 3a,b) . The complex appears also to be stabilized by polar interactions involving K213 and Q217 (Fig. 3b ). In the P. berghei complex, the residues located in equivalent positions are D173, Y174 and D175, with E205 and K209 stabilizing the complex through electrostatic interactions ( Fig. 3c,d ). To validate these predictions, we substituted the above amino acids for alanine to measure the effect of the substitutions on UIS3 binding to LC3. Simultaneous or individual mutations on all five residues abolished the interaction of sPfUIS3 with LC3 ( Fig. 3e,g) . Similarly, alanine substitutions of the equivalent positions in sPbUIS3 abrogated binding to LC3 almost completely ( Fig. 3f ). Of note, the circular dichroism (CD) spectra of recombinant sPfUIS3 proteins harbouring the above mutations did not reveal any significant effect of the amino acid substitutions on protein conformation (Fig. 3h ). Detailed analysis of the predicted LC3-UIS3 complexes from P. berghei and P. falciparum (Fig. 3a-d and Supplementary Fig. 5d,e ) indicated that the LC3 surface where UIS3 putatively binds coincides with the surface recognized by autophagy proteins containing canonical LIR motifs, such as p62 (refs 19, 20, 22 ). Mutations of key residues in this LIR-binding LC3 surface to alanine abolished the interaction between sPfUIS3 and LC3 (Fig. 3i ), as predicted. Thus, although UIS3 lacks a canonical LIR, our data demonstrate that the LIR-binding surface of LC3 can accommodate this atypical interaction.
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Because UIS3 and canonical LIR motifs interact with the same region of LC3, we next hypothesized that UIS3 might interfere with the binding of LIR-containing proteins to LC3, thus interrupting the autophagic flux. To examine whether the UIS3-LC3 interaction represents a physiological autophagy subversion mechanism, we quantified the impact of heterologous UIS3 expression on the autophagic flux of HeLa cells. As a readout for autophagy, we monitored p62 degradation in response to amino acid starvation 23, 24 . Strikingly, sPbUIS3 WT inhibited the degradation of p62 induced by amino acid depletion, whereas UIS3 mutants had no effect (Fig. 4a,b) . The data demonstrates that binding of UIS3 to LC3 disrupts the autophagic flux, hinting at the possibility that UIS3 functions as an autophagy inhibitor, through a hindrance effect on the LC3 surface. To explore this hypothesis, we set up a LUMIER-based competition assay 25 in which sPfUIS3 or p62 was complexed to GST-LC3 and subsequently incubated with increasing concentrations of the p62 LIR (ref. 22 ) (Fig. 4c ). We found that higher concentrations of p62 LIR were necessary to disrupt the UIS3-LC3 complex compared to p62-LC3 (Fig. 4d ). This is consistent with the lower K D measured for the UIS3-LC3 interaction (Fig. 2g ) compared to similar measurements for canonical LIR sequences 26 . To determine how pervasive the UIS3 hindrance effect was, we examined the impact of sPfUIS3 on the association between the LIR-containing Rab7 effector PLEKHM1 (ref. 27 ) and recombinant GST-LC3. When sPfUIS3 WT and PLEKHM1 were co-expressed, LC3 pulldowns were significantly depleted of PLEKHM1 and enriched in UIS3, whereas mutations that reduced the affinity of UIS3 for LC3 restored the PLEKHM1-LC3 association (Fig. 4e ). Taken together, these observations not only demonstrate that Plasmodium UIS3 antagonizes LIR-mediated LC3 interactions by binding to a conserved LIRinteracting surface on LC3, but they also confirm UIS3 as a bona fide autophagy inhibitor.
In this study, we show that Plasmodium parasites escape autophagy by engaging host LC3 in an inhibitory interaction with the cytosolic domain of the PVM transmembrane protein UIS3. Our observations demonstrate that UIS3 competitively inhibits the binding of LIR-containing host proteins to the LIR-docking surface of LC3. This strongly suggests that the UIS3-mediated protection against antiplasmodial autophagy is a direct consequence of LC3 being sequestered into UIS3-LC3 complexes on the PVM ( Fig. 4f and Supplementary Fig. 6 ). Although UIS3 is necessary to avert the potential deleterious effects of the association of LC3 to the PVM, whether Plasmodium succeeds in evading autophagy probably depends on how much of the PVM-associated LC3 is bound by UIS3. This, in turn, is determined by the levels of UIS3 expression and the robustness of the antiplasmodial response, both of which may diverge significantly between individual parasites and hosts, and could explain the vulnerability of P. berghei parasites to autophagy observed in previous reports 3, 4 .
Evidence that interferon (IFN)-γ enhances LC3 recruitment onto the PVM of Plasmodium vivax, causing parasite elimination 28 , supports the idea that host autophagy may be chemically enhanced to suppress the protective effect of UIS3 expression. Repurposing autophagy-inducing drugs for malaria prophylaxis might thus be a safe and cost-effective way of breaking the transmission cycle in endemic areas. Whether clinically available autophagy inducers activate the non-canonical autophagy pathway targeting Plasmodium in hepatic cells remains to be determined. Of note, neither metformin nor rapamycin, two of the best known autophagy-inducing drugs, affect the number of infected cells in vitro or in vivo 3, 8, 29 , supporting our observations that antiplasmodial autophagy is mechanistically distinct from the AMPK-and mTOR-regulated canonical autophagy pathway.
Recent reports underscored the risk of breakthrough infections in mice immunized with a uis3(−) P. berghei ANKA whole-organism vaccine 30 . The data presented here suggest that host genetic or metabolic factors compromising the autophagy response might be the cause of such breakthrough infections. Although insufficiently safe on its own, UIS3 deletion is likely to improve the safety of any genetically attenuated whole-organism vaccine against malaria by enhancing the susceptibility of hepatic parasites to host autophagy. Additionally, with the spread of drug resistance casting a shadow over malaria eradication efforts, the protein-protein interaction between UIS3 and LC3 constitutes a promising new target for tailored pharmacological interventions aiming at controlling Plasmodium liver infection and disease.
Methods
Chemicals. RPMI 1640, DMEM, EBSS and other cell culture reagents were purchased from Gibco Invitrogen. All chemicals were from Sigma-Aldrich, unless specified otherwise. Lipofectamine (Invitrogen) was used for transfection of HepG2 cells. siRNAs were transfected using Lipofectamine RNAiMAX in OptiMEM (Invitrogen).
Cell lines. Huh7, HepG2 and HEK 293T (ATCC) cells were cultured under standard conditions in RPMI 1640 (Huh7) or DMEM (HepG2 and HEK 293T) medium supplemented with 10% FCS, 1% non-essential aminoacids (RPMI 1640), 1% glutamine, 1% penicillin/streptomycin, and 1% Hepes. Mouse embryonic fibroblasts (MEFs) were obtained from the Riken BioResource Center (Atg5 +/+ (RCB2710) and Atg5 −/− (RCB2711) 31 , M. Komatsu, Tokyo Metropolitan Institute of Medical Science (Atg3 +/+ and Atg3 −/− ) 32 and T. Finkel, NIH National Heart, Lung, and Blood Institute (Atg7 +/+ and Atg7 −/− ) 33 . HeLa cells expressing GFP-LC3 were a gift from T. Hyman, MPI-CBG. MEFs and HeLa cells were maintained in DMEM supplemented as before. MEFs were validated through quantitative reverse transcription PCR (qRT-PCR) and HeLa cells were tested for the expression of Letters NaTUre MICrObIOLOgy GFP-LC3 by western blot. All cell lines were routinely tested for mycoplasma contamination.
Mice. All mice used in this study were C57BL/6J males, between 6 and 8 weeks of age, housed in the animal facility of the Instituto de Medicina Molecular in Lisbon. All protocols were approved by the internal animal care committee of the Instituto de Medicina Molecular and were performed according to national and European regulations.
Mouse primary hepatocytes. Mouse primary hepatocytes were isolated using a modified two-step perfusion protocol followed by a Percoll purification step 34, 35 . Briefly, mice were sacrificed by CO 2 inhalation and immediately processed for cannulation of the portal vein using a 26-gauge needle. Next, the inferior vena cava (IVC) was cut to allow fluid to drain. Liver perfusion medium (LPM) was perfused at 8-9 ml min -1 for 10 min, followed by liver digestion medium (LDM), also at a rate of 8-9 ml min -1 for 10 min. Intermittent clamping of the IVC (3 s clamp every 30 s) was performed during LDM perfusion to improve tissue digestion. After digestion, the liver was excised and the cells were liberated by tearing and shaking of the liver with forceps. The cell suspension was then sequentially filtered through a 100 μ m and a 70 μ m cell strainer and spun at 50g for 3 min. The cell pellet was resuspended in Williams's Medium E with 10% of fetal calf serum (FBS) and carefully overlaid on a 60% Percoll solution (1:1). The cell suspension was fractionated by centrifugation at 750g for 20 min, without break, at 20 °C. Viable hepatocytes deposited in the pellet were washed with Williams's Medium E with 10% FBS, spun at 50g for 3 min and resuspended in complete Williams's Medium E (supplemented with 4% FBS and 1% penicillin/streptomycin). Viability and yield were assessed by trypan blue staining. Viable hepatocytes were plated on collagen-coated 24-well plates.
RNAi. HepG2 cells were reverse-transfected with target-specific SMARTpool siRNA pools, as previously described 36 . Non-targeting SMARTpool siRNA was used as a negative control (Dharmacon, GE Healthcare). The efficiency of knockdown was assessed 48 h after transfection by qRT-PCR using kits from Applied Biosystems. Gene expression levels were normalized against those of hypoxanthine guanine phosphoribosyltransferase (Hprt1). The primer pairs used for qRT-PCR reactions are listed in Supplementary Table 3 .
Parasite lines. P. berghei sporozoites were obtained through dissection of the salivary glands of infected female Anopheles stephensi mosquitoes bred at the Instituto de Medicina Molecular. The following parasite lines were used: GFPexpressing P. berghei ANKA (259cl2, Leiden Malaria Research Group), uis3(−) 5 , uis3(+) and uis3-myc P. berghei NK65 (generated for this study).
Plasmodium transfection. P. berghei uis3-myc and uis3(+) were obtained by complementing the uis3(−) parasite line via single crossover recombination as described in Supplementary Fig. 2 . Transfection was carried out by electroporation of purified schizonts as previously described 37 . Parasites were selected with WR99210 (provided by Jacobus Pharmaceuticals) for four consecutive days, collected on day 10 post-transfection and genotyped by PCR with the primers listed in Supplementary Table 2 .
Infections. Hepatoma cells, MEFs and mouse primary hepatocytes were plated on 24-well culture plates at a density of 65,000, 50,000 and 120,000 cells per well, respectively. Cells were infected with freshly dissected P. berghei sporozoites (30.000 per well) 1 day after seeding and processed for analysis at 24 h or 48 h. siRNA-treated HepG2 cells were infected with uis3(+) or uis3(−) sporozoites 36 h after siRNA transfection and cultured for another 65 h in standard medium supplemented with 0.3% Fungizone. At 65 h, the entire volume of cell culture medium (HepG2 SN) in each well was collected and immediately inoculated into mice (1 well for each animal). The onset of blood-stage parasitaemia was monitored through Giemsa-stained thin blood smears by two unblinded independent observers. The smears were analysed daily from day 1 to day 10 after inoculation, when most animals suffered from hyperparasitaemia and had to be killed. On day 10, parasite genomic DNA was extracted from the blood of each experimental animal for parasite genotyping. The primer pairs used to probe the uis3 wild-type and knockout genomic loci are listed in Supplementary Table 2 . For ROS-scavenging experiments, Huh7 cells were incubated for 2 h in complete medium supplemented with 20 mM N-acetylcysteine (NAC), before sporozoite addition. Chloroquine (50 µ M) was added to hepatoma cells 1 h after sporozoite infection.
Plasmids.
The plasmids used in this study are listed in Supplementary Table 1 . All Plasmodium sequences (except single point mutants) and human LC3B were chemically synthesized and subcloned into pCMV-Myc-N or pCMV-HA-N expression vectors (Clontech) using the EcoRI and KpnI restriction sites (GeneArt, Invitrogen). The Renilla luciferase sequence was chemically synthesized (GeneArt, Invitrogen) and subcloned into pCMV-MYC-sPfUIS3 using the EcoRI restriction site. Single point mutants of sPfUIS3 were obtained by sitedirected mutagenesis using the primers listed in Supplementary Table 4 and the QuickChange II site-directed mutagenesis kit (Agilent Technologies), following the manufacturer's instructions. For production of His6-sPfUIS3 (WT and mutants), the soluble domain of P. falciparum UIS3 was amplified from pCMV-MYC-sPfUIS3 (forward primer: 5'CATGGGATCCATGGAGCAGAAGCTG3'; reverse primer: 5'CCGCGGTCTCGAGTCAGTTCTCTTCCT3) and cloned into pET28a (Novagen). All plasmids were verified by sequencing. Plasmodium sequences were optimized for expression in mammalian cells.
Immunofluorescence. Cells plated on glass coverslips were fixed in 4% paraformaldehyde (ChemCruz) for 10 min at room temperature (RT) and permeabilized/blocked with a solution of 0.2% saponin-1% BSA. For immunostaining, samples were incubated with primary antibodies diluted in blocking solution (2 h, RT), washed with PBS, incubated for 1 h at RT with AlexaFluor-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories) and Hoechst 33342 (Invitrogen) and washed again. The coverslips were then mounted on microscope slides with Fluoromount (SouthernBiotech). The following primary antibodies were used for confocal microscopy: LC3 (mouse monoclonal, MBL, M152-3), c-Myc (mouse monoclonal, MBL, M192-3), PbHSP70 (2E6 38 ), PbUIS4 29 (goat polyclonal, SicGen, AB0042-200), LAMP1 (rabbit polyclonal, Sigma, L1418) and PbMSP1 29 (rabbit polyclonal, GenScript, custommade). All images were acquired on Zeiss confocal microscopes (LSM 510 META or LSM 710) and processed in ImageJ. For co-localization analysis, the region of interest (ROI) corresponding to the PVM was defined by thresholding the UIS4 signal, after which the Manders coefficients M1 and M2 within the ROI were calculated using the Colocalisation Threshold plugin from ImageJ. For infection quantification by microscopy, parasites were detected with anti-PbHSP70 (2E6) and anti-PbMSP1 and imaged on a Zeiss Axiovert 200M wide-field microscope equipped with an automated stage. All images (42 per coverslip) were processed and analysed using ImageJ.
Immuno-EM. Huh7 cells were fixed 24 h after infection with 4%
paraformaldehyde-0.05% glutaraldehyde in 100 mM PIPES-0.5 mM MgCl 2 (pH 7.2) for 1 h at 4 °C and processed as described previously 39 . Sections were stained with antibodies against human LC3 (mouse monoclonal, MBL, M152-3) and UIS4 (goat polyclonal, SicGen, AB0042-200), followed by gold-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories), and viewed on a JEOL 1200 EX transmission electron microscope (JEOL).
Molecular docking of UIS3-LC3 complexes.
Homology models of the UIS3 soluble domains belonging to different Plasmodium species and human LC3 were built with the Phyre2 server (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id= index) using the crystal structures of P. falciparum UIS3 (PDB code: 2VWA) and LC3B (PDB code: 2ZJD) as reference models. The quality of the homology models obtained was improved by atomic coordinate refinement using a two-step atomic-level energy refinement protocol implemented in ModRefiner software 40 . Experimental and homology-derived protein coordinates were then used to construct models of the human and mouse UIS3-LC3 complexes by flexible molecular docking with the Swarmdock algorithm 41 . LC3 proteins were considered as receptors and UIS3 as ligands. For each complex, an initial set of 100 ligand starting positions was generated in the space around the receptor, being further optimized by energy minimization. The top 10 docking solutions were ranked by increasing free energy and submitted to an additional energy minimization cycle by conjugated gradient during 1,000 steps with GROMACS 42 , to avoid potential steric clashes between contact atoms. Visual inspection and cross comparison between the docking results obtained for the human and mouse complex showed a conserved pattern of molecular orientations for the top five docking solutions. Consensus residues involved in UIS3-LC3 interactions in the best docking solution were determined using CONS-COCOMAPS application 43 and graphically represented with LigPlot+ software 44 . Table 1 ) on 10 cm dishes and collected 48 h after transfection in lysis buffer (0.5% NP-40, 150 mM NaCl, 10 mM Tris-Cl pH 7.4, 0.5 mM EDTA) supplemented with Complete protease inhibitor and PhosStop phosphatase inhibitor cocktails (Roche). On some experiments, HeLa cells were co-transfected with both myc-UIS3 and HA-tagged LC3. c-Myc-and HA-tagged proteins were purified from total cell lysates using the c-Myc-tagged protein mild purification kit and the HA-tagged protein purification kit, respectively, according to the manufacturer's instructions (MBL). GFP-LC3 was immunoprecipitated from total cell lysates using GFP-Trap coupled to agarose beads (Chromotek). For immunoprecipitation of parasite-encoded UIS3-myc from infected cells, HeLa cells or mouse primary hepatocytes were lysed 24 h after infection with uis3-myc P. berghei and total cell lysates were processed as described above. Co-immunoprecipitated proteins and total cell lysates were analysed by western blot using antibodies against LC3 (rabbit polyclonal, MBL, PM036) and c-Myc (mouse monoclonal, MBL, M192-3) or HA tags (mouse monoclonal, Biolegend, 901503) to detect UIS3 or UIS4, followed by HRP-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories). Immunoblots were developed using Luminata Crescendo Western HRP substrate reagent (Merck Millipore).
Co-immunoprecipitation. HeLa cells expressing GFP-LC3 were transfected with plasmids encoding c-Myc or HA fusion proteins (Supplementary
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Expression and purification of recombinant proteins. Escherichia coli BL21 cells were transformed with GST-His-tagged LC3 or GST-His bacterial expression vectors. After overnight culture in Luria-Bertani (LB) broth, cells were diluted 1/100 in fresh medium to an optical density (OD) of ~0.7 and incubated with 0.3 mM IPTG for 5 h to induce expression of the recombinant proteins. All cultures were performed at 37 °C with vigorous shaking. For expression of Histagged sPfUIS3 WT , E. coli BL21 C43 bacteria were used. Cells grown overnight in LB broth were diluted 1/100 in fresh medium to an OD of ~1.2. Recombinant protein expression was induced by the addition 0.3 mM IPTG and overnight culture at 25 °C. His-tagged sPfUIS3 mutants were expressed in E. coli BL21 bacteria. Overnight cell cultures were diluted 1/100 in LB supplemented with NZY auto-induction reagent (NZYTech). Recombinant His-tagged proteins were initially purified by metal chelating affinity chromatography using His-Trap Ni-containing columns (GE Healthcare) connected to an AKTA Explorer chromatographic system (GE Healthcare). The His-trap column (1 ml bed volume) was equilibrated with sodium phosphate buffer pH 6.8 containing 1 M NaCl and 25 mM imidazole before protein injection. His-tagged proteins were eluted by a linear gradient of imidazole from 25-500 mM in the same phosphate buffer. Fractions containing protein were collected and pooled and further polished by size exclusion chromatography purification using a Sephadex S-200 column (GE Healthcare) eluted with PBS. Fractions containing protein were analysed by SDS-PAGE, concentrated by ultrafiltration and stored at − 80 °C in PBS buffer containing 15% glycerol.
Interaction between recombinant proteins. Recombinant sPfUIS3 (5 µ g) was incubated with recombinant GST-His6-LC3 (10 µ g) or with GST-His6 (5 µ g), preadsorbed to glutathione beads in lysis buffer (150 mM NaCl, 20 mM Tris-HCl (pH 7.4), 0.1% Triton-X100, 5% glycerol, 5 mM EDTA and Complete protease inhibitors (Roche)). After washing, the complex was eluted in lysis buffer supplemented with 10 mM reduced l-glutathione (Sigma-Aldrich) and analysed by western blot with antibodies against LC3 (rabbit polyclonal, MBL, PM036) and c-Myc (mouse monoclonal, MBL, M192-3).
Surface plasmon resonance. Recombinant sPfUIS3 was immobilized on a Biacore CM5 chip surface following standard protocols provided by the manufacturer (GE Healthcare). In brief, recombinant sPfUIS3 was chemically immobilized via amine coupling to the free carboxyl groups on the CM5 chip through standard NHS (N-hydroxysuccinimide) and EDC (N-ethyl-N'-(dimethylaminopropyl) carbodiimide) activation procedures. Recombinant GST-His-LC3 dissolved in PBS buffer was injected over the immobilized sPfUIS3 at various concentrations to generate affinity sensorgrams that were collected in a single-cycle mode with no regeneration between sample injections. Unspecific binding was monitored by injecting recombinant GST-His protein over the sPfUIS3-coated chip under the same conditions. Normalized response sensorgrams were calculated by subtracting the unspecific binding contribution of the same molar concentrations of GST protein alone. All biosensor data processing and analysis and K D calculations were performed using the Biacore T100 Evaluation Software (GE Healthcare version 2.01). For K D calculation, a monovalent interaction model was assumed, with both proteins interacting with 1:1 stoichiometry. Circular dichroism. Recombinant His-tagged sPfUIS3 proteins (wild type and mutants) used for circular dichroism were purified using a modification of the already described protocol, where the elution buffer of the size exclusion chromatography was substituted by 50 mM sodium phosphate, 200 mM NaF, pH 7.5. CD spectra of sPfUIS3 variants were collected between 190 and 260 nm in a JASCO J-815 spectropolarimeter (Tokyo, Japan) using 1 mm quartz cells from Hellma Analytics. Experiments were performed at 25 °C. Each CD spectrum corresponds to the average of 10 technical replicates, corrected for the buffer background contribution. Mean molar residue ellipticity values, [θ], were determined through the relationship 45
where θ is the observed ellipticity, N is the number of amino acid residues in each protein, l is the quartz cell optical path length and c is the protein molar concentration.
Autophagy induction and p62 degradation assay. HeLa cells were changed from normal growth medium to EBSS to induce amino acid starvation-dependent autophagy. After 7 h, cells were collected in Laemmli buffer and analysed by western blot with antibodies against p62 (rabbit polyclonal, Sigma-Aldrich, P0067) and gamma-tubulin (mouse monoclonal, Sigma-Aldrich, T5326). The levels of p62 were measured by quantifying the ratio of p62 to tubulin signals with ImageJ. Table 1 ) were lysed 24 h post-transfection in LUMIER lysis buffer (150 mM NaCl, 20 mM Tris-HCl (pH 7.4), 0.1% Triton-X100, 5% glycerol, 5 mM EDTA and Complete protease inhibitors (Roche)) 25 . The Renilla luciferase activity associated with each cell lysate was assessed using the Renilla Luciferase Assay System (Promega). Equivalent saturating amounts of luciferase-tagged p62 or sPfUIS3 cell lysates were incubated with recombinant GST-His6-LC3B (500 ng), pre-adsorbed to glutathione beads. After washing away unbound protein, the precipitates were incubated with increasing concentrations of synthetic p62 LIR peptide (SGGDDDWTHLSSK) for 1 h with rotation, followed by elution in lysis buffer supplemented with 10 mM reduced l-glutathione (Sigma-Aldrich). The Renilla luciferase activity associated with LC3 after elution was quantified as described above using Tecan's Infinite 200M multiplate reader. The expression of luciferase-tagged p62 or sPfUIS3 was additionally detected with an anti-Renilla luciferase antibody (Abcam). LUMIER/GFP assay. HEK 293T cells transiently transfected with PLEKHM1-GFP 46 and co-transfected with empty plasmid, Luc-sPfUIS3 WT or Luc-sPfUIS3 Mut1 ( Supplementary Table 1 ) were lysed 24 h post-transfection in LUMIER lysis buffer (150 mM NaCl, 20 mM Tris-HCl (pH 7.4), 0.1% Triton-X100, 5% glycerol, 5 mM EDTA and Complete protease inhibitors (Roche)). The cell lysates were incubated with recombinant GST-His6-LC3B (500 ng), pre-adsorbed to glutathione beads, for 2 h at 4 °C, with rotation. After washing away unbound proteins, pulldowns were eluted in lysis buffer supplemented with 10 mM reduced l-glutathione. GFP (excitation 420 nm, emission 520 nm) and Renilla luciferase activity associated with LC3 in each experimental condition were quantified using Tecan's Infinite 200M multiplate reader.
LUMIER competition assay. HEK 293T cells transiently transfected with Luc-p62 or Luc-sPfUIS3 expressing plasmids (Supplementary
Statistical analysis. Data are expressed as means + s.e.m. Statistically significant differences between two different groups were determined using non-parametric two-tailed-Mann-Whitney test, unpaired two-tailed t-test or two-way ANOVA, as indicated. P values < 0.05 were considered statistically significant. Significances are represented in the figures as follows: NS, P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ***P < 0.0001. All tests were carried out in GraphPad Prism. The experiments were not randomized. Sample sizes on mice experiments were chosen on the basis of historical data, and no statistical methods were used to predetermine sample size.
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Data availability. The data supporting the findings of this study are available within the paper and its Supplementary Information. 
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Experimental design 1. Sample size
Describe how sample size was determined.
No statistical methods were used to pre-determine sample size. The sample size is specified in each figure legend and in Supplementary Table 5 .
Data exclusions
Describe any data exclusions. No data were excluded from the analysis.
Replication
Describe whether the experimental findings were reliably reproduced.
All attempts at replication were successful.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Microscopy analysis were performed on randomly acquired images. Mice were randomly assigned to each experimental group.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
No blinding was performed.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
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A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
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A description of any assumptions or corrections, such as an adjustment for multiple comparisons
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